Gimv - News

05/03/2020 - 10:46 Portefeuille

Gimv invests in AME, specialised producer of smart electronics for tomorrow’s products, located in Eindhoven Brainport

20/02/2020 - 17:50 Portefeuille

Gimv to enter partnership with Köberl Group to achieve further growth in the facility management and technical building services sector

18/02/2020 - 11:44 Portefeuille

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

06/02/2020 - 18:24 Portefeuille

JenaValve Technology Closes USD 50 Million Financing

23/01/2020 - 11:39 Portefeuille

General Fusion Closes $65M of Series E Financing - Gimv contribue à la recherche d'une réponse pour un avenir énergétique décarboné

19/12/2019 - 09:22 Portefeuille

Topas Therapeutics annonce le premier patient inscrit dans le Trial de phase 1 avec TPM203 dans Pemphigus vulgaris

12/12/2019 - 09:00 Portefeuille

Cegeka reinforces international position by acquiring KPN Consulting

04/12/2019 - 06:45 Portefeuille

Imcheck Therapeutics lève 53 millions de dollars, Gimv renforce son investissement dans le domaine de l'immuno-oncologie

27/11/2019 - 10:27 Portefeuille

Soutenu par Gimv, le groupe Claire acquiert Ijinus et renforce ainsi son pôle de produits communicants

21/11/2019 - 07:00 Financier

Poursuite de la croissance et rendement du portefeuille toujours solide

29/10/2019 - 15:43 Portefeuille

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

14/10/2019 - 08:00 Portefeuille

Eric de Montgolfier nommé CEO d'Invest Europe

09/09/2019 - 16:50 Portefeuille

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

09/09/2019 - 13:46 Portefeuille

Equipe Zorgbedrijven envisage de reprendre la clinique ophtalmologique Heuvelrug

05/09/2019 - 08:00 Portefeuille

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

30/07/2019 - 08:00 Portefeuille

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

30/07/2019 - 07:45 Portefeuille

Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software.

30/07/2019 - 07:30 Portefeuille

Gimv sort du capital de Legallais, le spécialiste de la distribution de solutions pour les professionnels du bâtiment en France.

25/07/2019 - 08:00 Portefeuille

Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development

26/06/2019 - 17:45 Financier

Report of the Annual General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share

21/06/2019 - 17:45 Financier

Closure of the subscription periods for the bond issue for private and institutional investors for the total maximum amount of EUR 250 million

19/06/2019 - 07:30 Financier

Gimv NV launches a bond-issue for retail and institutional investors for a total nominal amount of at least EUR 150 million

Filtrer communiqués de presse:

Biotalys announces second closing Series C totaling €45m

Itineris is looking for 60 new employees to accelerate growth

Alro is nominated trendsgazelle ambassador for medium sized companies

Gimv invests in AME, specialised producer of smart electronics for tomorrow’s products, located in Eindhoven Brainport

Gimv to enter partnership with Köberl Group to achieve further growth in the facility management and technical building services sector

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

JenaValve Technology Closes USD 50 Million Financing

General Fusion Closes $65M of Series E Financing - Gimv contribue à la recherche d'une réponse pour un avenir énergétique décarboné

Topas Therapeutics annonce le premier patient inscrit dans le Trial de phase 1 avec TPM203 dans Pemphigus vulgaris

Cegeka reinforces international position by acquiring KPN Consulting

Imcheck Therapeutics lève 53 millions de dollars, Gimv renforce son investissement dans le domaine de l'immuno-oncologie

Soutenu par Gimv, le groupe Claire acquiert Ijinus et renforce ainsi son pôle de produits communicants

Poursuite de la croissance et rendement du portefeuille toujours solide

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

Eric de Montgolfier nommé CEO d'Invest Europe

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

Equipe Zorgbedrijven envisage de reprendre la clinique ophtalmologique Heuvelrug

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software.

Gimv sort du capital de Legallais, le spécialiste de la distribution de solutions pour les professionnels du bâtiment en France.

Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development

Report of the Annual General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share

Closure of the subscription periods for the bond issue for private and institutional investors for the total maximum amount of EUR 250 million

Gimv NV launches a bond-issue for retail and institutional investors for a total nominal amount of at least EUR 150 million